GLP-1 weight-loss drugs offer promising results but come with potential risks and unknown long-term effects, emphasizing the ...

With more studies emerging, GLP-1 and dual GIP/GLP-1 medications have become well-established options for those with obesity or type 2 diabetes.

A growing number of lawsuits alleged that the manufacturers of certain GLP-1 drugs like Ozempic, Wegovy, and Mounjaro failed ...

University Hospitals cardiologist explains the benefits, side effects, and future of these increasingly popular drugs.

Everyday Health independently vets all recommended products. If you purchase a featured product, we may be compensated. Learn why you can trust us. ON THIS PAGE Featured Partner While Ozempic has been ...

Custom formulations of popular weight loss medications have surged in popularity due to the high costs of FDA-approved drugs.

Tia Timmer was always “on the heavier side,” but her weight never held her back – until she had to keep up with two grandchildren.

Are GLP-1 drugs prescribed for weight loss becoming too outsized a line item for continued coverage through the state ...

The rapid adoption of GLP-1 weight loss medications — drugs like Novo Nordisk's Ozempic and Wegovy and Eli Lilly's Zepbound and Mounjaro — is reshaping how Americans eat and shop. It's also changing ...

Wegovy is currently not listed on the PBS and not subsidied by the Australian government.

The Trump administration has announced a pricing initiative designed to reduce the cost of glucagon-like peptide-1 (GLP-1) drug products for certain Medicare enrollees. This policy represents a ...